Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study

Background: Thrombosis with thrombocytopenia syndrome (TTS) has been identified as a rare adverse event following some COVID-19 vaccines. Various guidelines have been issued on the treatment of TTS. We aimed to characterize the treatment of TTS and other thromboembolic events (venous thromboembolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Markus, Aniek F., Strauss, Victoria Y., Burn, Edward, Li, Xintong, Delmestri, Antonella, Reich, Christian, Yin, Can, Mayer, Miguel A., Ramírez-Anguita, Juan-Manuel, Marti, Edelmira, Verhamme, Katia M. C., Rijnbeek, Peter R., Prieto-Alhambra, Daniel, Jödicke, Annika M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079887/
https://www.ncbi.nlm.nih.gov/pubmed/37033631
http://dx.doi.org/10.3389/fphar.2023.1118203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079887/
https://www.ncbi.nlm.nih.gov/pubmed/37033631
http://dx.doi.org/10.3389/fphar.2023.1118203

Ejemplares similares